Phototherapy in Wound Care: LED and Low-Level Laser

Phototherapy in Wound Care: Science Behind Light-Based Healing

Phototherapy for wound healing, also called photobiomodulation (PBM), uses specific wavelengths of light to stimulate cellular processes involved in tissue repair. Low-level laser therapy (LLLT) and LED-based phototherapy represent two delivery mechanisms for the same underlying biological effect. Both have a growing evidence base in wound care, though their clinical adoption lags behind other modalities.

The concept is counterintuitive: shining light on a wound can accelerate healing. But the mechanism is well-characterized at the cellular level, and understanding it helps clinicians evaluate whether phototherapy has a role in their practice.

Mechanism of Action: How Light Promotes Healing

Photobiomodulation at the Cellular Level

The biological mechanism of phototherapy centers on cytochrome c oxidase, a photoacceptor molecule in the mitochondrial electron transport chain. When specific wavelengths of light (typically 600-1000 nm) are absorbed by cytochrome c oxidase, the result is:

Increased ATP production: Enhanced mitochondrial respiration produces more cellular energy, fueling repair processes
Reactive oxygen species (ROS) signaling: Low-level ROS generated by photon absorption activate transcription factors (NF-kB, AP-1) that upregulate genes involved in cell proliferation, migration, and growth factor production
Nitric oxide release: Photodissociation of nitric oxide from cytochrome c oxidase increases local blood flow and promotes angiogenesis
Reduced inflammation: Modulation of inflammatory mediators shifts the wound environment from pro-inflammatory to pro-reparative

Therapeutic Windows

The biological response to phototherapy follows a biphasic dose-response pattern (Arndt-Schulz curve):

Too little energy: Insufficient photon absorption; no biological effect
Optimal dose (1-10 J/cm²): Stimulatory effects on cell proliferation, migration, and growth factor production
Too much energy: Inhibitory effects; can actually impair healing

This dose-response relationship explains why treatment parameters matter and why "more light" is not better.

LLLT vs LED: Understanding the Devices

Low-Level Laser Therapy (LLLT)

LLLT uses coherent, monochromatic light from laser diodes. The light is focused and penetrates tissue at a specific wavelength.

Characteristics:

Coherent light (waves in phase)
Single wavelength (typically 630-670 nm for superficial or 780-860 nm for deeper tissue penetration)
Higher power density at the point of application
Smaller treatment area per application point
Higher device cost

LED Therapy

LED arrays produce non-coherent, near-monochromatic light across a broader beam. They can treat larger wound areas simultaneously.

Characteristics:

Non-coherent light
Narrow bandwidth around a central wavelength (not truly monochromatic)
Lower power density but larger treatment area
Multiple LEDs cover the wound surface uniformly
Lower device cost and simpler maintenance

Clinical Equivalence

The evidence suggests that coherence (the distinguishing property of laser vs LED) is not required for photobiomodulation. The critical parameters are wavelength, energy density (J/cm²), and power density (mW/cm²), not whether the light source is laser or LED. LED devices that deliver appropriate parameters at effective wavelengths produce comparable biological effects at lower cost.

Evidence Review: Phototherapy for Wound Healing

What the Studies Show

Diabetic foot ulcers: Multiple RCTs have demonstrated improved healing rates with LLLT/LED therapy when added to standard wound care. A systematic review in Photomedicine and Laser Surgery found significant wound area reduction in treated groups versus controls.

Venous leg ulcers: Limited but positive evidence. Studies show improved pain reduction and healing rates, though sample sizes are generally small.

Pressure injuries: Mixed results. Some trials show benefit, others show no significant difference from standard care. Study heterogeneity in treatment parameters makes comparison difficult.

Post-surgical wounds: Moderate evidence supports reduced inflammation, improved tensile strength, and faster closure in surgical incisions treated with photobiomodulation.

Limitations of the Evidence

The phototherapy evidence base suffers from the same challenge as many wound care modalities: parameter heterogeneity. Studies vary widely in:

Wavelength (from 630 nm to 1000 nm)
Energy density (from 0.5 to 50 J/cm²)
Treatment duration and frequency
Device type (laser vs LED vs superluminous diode)

This makes it difficult to establish definitive treatment protocols, and it is the primary reason phototherapy has not achieved the same level of guideline recommendation as electrical stimulation.

For context on evaluating evidence for emerging wound care therapies, see Evidence-Based Practice in Wound Care.

Clinical Application and Device Selection

Treatment Parameters (Based on Available Evidence)

Wavelength: 630-670 nm (red light) for superficial wounds; 780-860 nm (near-infrared) for deeper tissue penetration
Energy density: 2-8 J/cm² per session (within the stimulatory window)
Treatment frequency: 3-7 times per week, depending on wound type and clinical response
Treatment duration: Determined by device power output and target energy density; typically 1-10 minutes per treatment area

Device Selection Criteria

When evaluating phototherapy devices for wound care:

FDA clearance: Verify the device is FDA-cleared for wound healing indications (not just pain management or cosmetic use)
Wavelength specification: The device should clearly state the wavelength(s) delivered, not just "red light" or "infrared"
Power output documentation: Required to calculate treatment dose (energy density = power x time / area)
Treatment area coverage: LED panels that cover the wound area uniformly are more practical for wound care than point-source lasers that require scanning
Clinical support: Manufacturer should provide evidence-based treatment protocols, not just marketing materials

Regulatory Considerations

Phototherapy devices for wound care are regulated as Class II medical devices by the FDA and require 510(k) clearance. Clinicians should verify that any device used in clinical practice has appropriate clearance for wound healing indications.

Important distinction: Many LED devices marketed for wellness, skin rejuvenation, or pain management are NOT cleared for wound healing. Using a device outside its cleared indications creates liability risk and may not be reimbursable.

For a broader look at growth factor therapies and biologic approaches that can complement phototherapy, see Growth Factors and Biologics in Wound Care.

Key Takeaways

Photobiomodulation works through cytochrome c oxidase absorption in mitochondria, increasing ATP production, promoting angiogenesis via nitric oxide release, and modulating inflammation
LED and LLLT produce comparable biological effects at the cellular level; the critical treatment parameters are wavelength and energy density, not whether the light source is coherent
The biphasic dose-response (Arndt-Schulz curve) means treatment parameters must be precise: too little light produces no effect, and too much can inhibit healing
Evidence is strongest for diabetic foot ulcers and post-surgical wounds; pressure injury evidence remains mixed due to study heterogeneity
Devices must be FDA-cleared specifically for wound healing indications; wellness or cosmetic LED devices are not appropriate for clinical wound care